menu
    • menu

    Company profile for Korro Bio

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    KORRO BIO IS CREATING TRANSFORMATIVE THERAPEUTICS for patients by selectively editing messenger RNA to recode specific codons to deliver a beneficial change in protein sequence, structure and function.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Korro BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    KORRO BIO, INC. ‍400 Technology Square, ​10th Floor Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.korrobio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Korro Lays Off Staff As Lead Drug Disappoints, Novo Pauses Pact
    Korro Lays Off Staff As Lead Drug Disappoints, Novo Pauses Pact

    13 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/korro-lays-34-staff-lead-drug-disappoints-and-novo-nordisk-pauses-pact

    FIERCE BIOTECH
    13 Nov 2025
    Share Share
    Korro Updates Q3 Financials, Progress On KRRO-110
    Korro Updates Q3 Financials, Progress On KRRO-110

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186799/0/en/Korro-Reports-Third-Quarter-Financial-Results-Provides-Updates-on-KRRO-110-in-Alpha-1-Antitrypsin-Deficiency-and-Additional-Pipeline-Programs.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    Korro to Present at Investor and Scientific Conferences
    Korro to Present at Investor and Scientific Conferences

    02 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/02/3143181/0/en/Korro-to-Participate-in-Upcoming-Investor-and-Scientific-Conferences.html

    GLOBENEWSWIRE
    02 Sep 2025
    Share Share
    Korro's Q2 2025 Financial Results and Business Updates
    Korro's Q2 2025 Financial Results and Business Updates

    12 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/12/3131541/0/en/Korro-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Updates.html

    GLOBENEWSWIRE
    12 Aug 2025
    Share Share
    Korro Gets EMA Orphan Drug Designation for KRRO-110
    Korro Gets EMA Orphan Drug Designation for KRRO-110

    21 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/21/3118672/0/en/Korro-Receives-European-Medicines-Agency-Orphan-Drug-Designation-for-KRRO-110.html

    GLOBENEWSWIRE
    21 Jul 2025
    Share Share
    Korro to Participate in Upcoming Investor Conferences
    Korro to Participate in Upcoming Investor Conferences

    14 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/14/3081589/0/en/Korro-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    14 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search